The University of Chicago Header Logo

Olwen Hahn

Concepts (198)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Olwen Hahn's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Olwen Hahn has written about over time.
Enzyme Inhibitors, 2 publications between 2005 and 2007, average publication date July 2006. Benzenesulfonates, 2 publications between 2006 and 2008, average publication date October 2007. Antineoplastic Agents, 8 publications between 2005 and 2018, average publication date July 2011. Carcinoma, Small Cell, 2 publications between 2007 and 2017, average publication date August 2012. Comparative Effectiveness Research, 1 publications between 2012 and 2012, average publication date October 2012. Lung Neoplasms, 5 publications between 2005 and 2018, average publication date February 2013. Kidney Neoplasms, 7 publications between 2006 and 2019, average publication date August 2013. Carcinoma, Renal Cell, 5 publications between 2008 and 2019, average publication date June 2015. Pyridines, 8 publications between 2006 and 2021, average publication date November 2016. Bevacizumab, 8 publications between 2011 and 2022, average publication date July 2017. Capecitabine, 3 publications between 2011 and 2021, average publication date September 2017. Antineoplastic Combined Chemotherapy Protocols, 20 publications between 2011 and 2024, average publication date August 2019. Students, Medical, 3 publications between 2016 and 2023, average publication date September 2019. Neoplasms, 6 publications between 2016 and 2023, average publication date September 2019. Prostatic Neoplasms, 5 publications between 2017 and 2022, average publication date April 2020. Breast Neoplasms, 18 publications between 2012 and 2024, average publication date October 2020. Triple Negative Breast Neoplasms, 4 publications between 2014 and 2024, average publication date January 2021. Neoadjuvant Therapy, 8 publications between 2014 and 2024, average publication date January 2021. Receptor, ErbB-2, 7 publications between 2018 and 2024, average publication date December 2021. Chemotherapy, Adjuvant, 5 publications between 2020 and 2024, average publication date June 2022.

To see the data from this visualization as text, click here.
Hahn's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (198)
Explore
_
Co-Authors (52)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_